CS
STJ

Cannell & Spears’s St Jude Medical STJ Stock Holding History

Cannell & Spears’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,710
Closed -$538K – 131
2015
Q4 		$538K Buy
+8,710
New +$549K 0.06% 79

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Cannell & Spears's STJ Position: Q1 2016 in Review

Cannell & Spears sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 8,710 shares — an estimated $538K sold.

Cannell & Spears first reported a position in STJ in Q4 2015 and held it in 1 quarter. The position peaked at $538K in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Cannell & Spears reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Cannell & Spears sold 8,710 St Jude Medical shares in Q1 2016, an estimated $538K.
  • Cannell & Spears first reported a position in St Jude Medical in Q4 2015 and held it in 1 quarter.
  • Cannell & Spears's St Jude Medical position peaked at $538K in Q4 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Cannell & Spears's 13F filing for Q1 2016, filed 13 May 2016.